Severance Hospital
| Republic of Korea | Thailand | Turkey | |
| Bacillus Calmette-Guérin (BCG) therapy | - | from AUD $2,149 | from AUD $1,719 |
No hidden fees – just official clinic prices. Pay at the clinic for Bacillus Calmette-Guérin (BCG) therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Bacillus Calmette-Guérin (BCG) therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Bacillus Calmette-Guérin (BCG) therapy journey.
South Korea faces a persistent BCG shortage for bladder cancer treatment. This mirrors global supply constraints starting in 2016. Major hospitals now prioritise high-risk cases. Medical centres use alternative therapies like intravesical gemcitabine to manage patient care without delays.
Bookimed Expert Insight: While a global shortage exists, Seoul centres like Severance Hospital remain remarkably resilient. They maintain partnerships with American institutions like MD Anderson. This collaboration means they follow the latest clinical guidelines for dosing. They successfully use alternative drugs when BCG supplies tighten.
Patient Consensus: Patients find that South Korean hospitals manage treatment gaps efficiently. They often suggest checking supply with local specialists before travel. Doctors here explain alternative chemotherapy options clearly so no one misses vital care.
South Korean clinics provide effective alternatives when BCG (Bacillus Calmette‑Guerin) is unavailable. These include intravesical gemcitabine, docetaxel, mitomycin C, pembrolizumab immunotherapy, and radical cystectomy. Specialist oncology centres in Seoul maintain high standards through JCI-accredited facilities and international cancer centre partnerships.
Bookimed Expert Insight: Leading Seoul facilities like Severance Hospital maintain formal partnerships with MD Anderson and Johns Hopkins. This gives patients access to the same evidence-based alternatives used in top American cancer centres. When BCG is scarce, these clinics rely on high-volume robotic surgery expertise to manage complex cases.
Patient Consensus: Patients value the quick switch to alternative drugs like gemcitabine at modern Korean hospitals. The coordination between specialists keeps treatment on schedule even during global supply shortages.
BCG bladder instillation in South Korea typically causes mild flu-like symptoms and urinary irritation within 48 hours. Specialists at major centres like Severance Hospital manage these effects to prevent treatment delays. Serious complications like BCG infection are rare. Patients often find symptoms manageable with standard medications.
Bookimed Expert Insight: Leading Seoul hospitals like Severance Hospital are JCI-accredited and perform over 40,000 operations annually. This high volume means oncology teams are experts at identifying BCG-related infections early. They often partner with global institutions like MD Anderson to follow the latest immunotherapy safety standards.
Patient Consensus: South Korean clinics provide clear protocols for managing common urinary discomfort and temporary fatigue. Patients feel supported when hospitals offer direct emergency contact for any persistent fever or unusual symptoms.
BCG therapy is an intravesical immunotherapy. It uses a weakened tuberculosis bacterium to treat non-muscle-invasive bladder cancer. Specialists in Seoul inject the medication directly into the bladder via a catheter. This triggers an immune response that attacks early-stage cancer cells and prevents tumours from returning.
Bookimed Expert Insight: Major Seoul centres like Severance Hospital partner with top-tier US oncology institutions. This collaboration brings the latest protocols to Korea. Patients often save up to _price_percent_discount_% compared to Australian costs. These savings include access to JCI-accredited facilities and the latest surgical technology.
Patient Consensus: South Korean hospitals are well-equipped for urological cancer treatments. Patients mention TB screenings are routine there. Specialists follow a strict regimen. Patients should expect total professionalism during the weekly sessions. Simple steps like using bleach at home are standard procedure.
Patients should contact their urologist in South Korea immediately if they run a fever above 38.5°C that lasts more than 24 hours. Seek urgent medical attention for severe bladder pain, heavy bleeding, shaking chills, confusion, or extreme fatigue. These symptoms can signal a serious systemic infection.
Bookimed Expert Insight: Major Seoul centres like Severance Hospital handle 1.6 million outpatients annually and maintain dedicated international centres. Patients benefit from these high-volume oncology units because they have 24-hour coordination teams. These teams provide direct English-speaking lines for emergency symptom triage during BCG therapy.
Patient Consensus: Save a Korean translation of your emergency symptoms and the 119 emergency number. Mild discomfort and pink-tinged urine are normal, but never ignore a high fever.
Specialists in South Korea administer BCG therapy. This is the primary immunotherapy for high-risk non-muscle-invasive bladder cancer. Treatment typically begins 2 to 4 weeks after TURBT surgery. This allows the bladder lining to heal. Doctors then place the medicine directly into the bladder via a catheter.
Bookimed Expert Insight: While many global protocols extend maintenance to 36 months, major Seoul centres like Severance Hospital often use a condensed 15-month schedule. This hospital treats 4,000,000 patients annually. It partners with MD Anderson to align with the latest oncology standards.
Patient Consensus: Patients find the 2-hour urine retention manageable but emphasise staying near the hospital. They suggest confirming full-dose availability in Seoul. This is because some global clinics have reported supply shortages.
BCG therapy in South Korea follows a standard schedule. It starts with an induction course of weekly sessions for 6 consecutive weeks. Clinics like Seoul's Severance Hospital often prescribe maintenance doses every 3 to 6 months. This immunotherapy treats non-muscle-invasive bladder cancer after surgery.
Bookimed Expert Insight: Clinical data shows top Seoul centres like Severance Hospital partner with MD Anderson in the US. This means Korean BCG protocols match the world's highest oncology standards. While the induction phase is fixed, maintenance schedules are highly personalised based on patient response.
Patient Consensus: Patients in South Korea describe the 2-hour waiting period as the most critical step. They suggest bringing previous diagnostic imaging to help specialists plan the precise maintenance timeline.